These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 2031508

  • 1. Advanced colorectal carcinoma. A prospective randomized trial of sequential methotrexate, 5-fluorouracil, and leucovorin versus 5-fluorouracil alone.
    Machiavelli M, Leone BA, Romero A, Rabinovich MG, Vallejo CT, Bianco A, Pérez JE, Rodríguez R, Cuevas MA, Alvarez LA.
    Am J Clin Oncol; 1991 Jun; 14(3):211-7. PubMed ID: 2031508
    [Abstract] [Full Text] [Related]

  • 2. Biochemical modulation of 5-fluorouracil with methotrexate in advanced colorectal cancer patients pretreated with adjuvant 5-fluorouracil and leucovorin.
    Pronzato P, Vaira F, Vigani A, Losardo P, Bertelli G.
    Anticancer Res; 1995 Jun; 15(6B):2679-82. PubMed ID: 8669846
    [Abstract] [Full Text] [Related]

  • 3. Randomized multicenter phase II trial of bolus plus infusional fluorouracil/leucovorin compared with fluorouracil/leucovorin plus oxaliplatin as third-line treatment of patients with advanced colorectal cancer.
    Kemeny N, Garay CA, Gurtler J, Hochster H, Kennedy P, Benson A, Brandt DS, Polikoff J, Wertheim M, Shumaker G, Hallman D, Burger B, Gupta S.
    J Clin Oncol; 2004 Dec 01; 22(23):4753-61. PubMed ID: 15570076
    [Abstract] [Full Text] [Related]

  • 4. [Chronotherapy with high dose carboplatin, 5-fluorouracil and leucovorin in advanced colorectal carcinoma].
    Popov I, Jelić S, Radosavljević D, Nikolić-Tomasević A.
    Srp Arh Celok Lek; 1998 Dec 01; 126(9-10):355-61. PubMed ID: 9863407
    [Abstract] [Full Text] [Related]

  • 5. Randomised study of tegafur and oral leucovorin versus intravenous 5-fluorouracil and leucovorin in patients with advanced colorectal cancer.
    Nogué M, Salud A, Batiste-Alentorn E, Saigí E, Losa F, Cirera L, Méndez M, Campos JM, Galan A, Escudero P, Arcusa A, Manzano H, de Mendizábal EV, de Olaguer JP, Boleda M, Guasch I, Vicente P.
    Eur J Cancer; 2005 Oct 01; 41(15):2241-9. PubMed ID: 16214045
    [Abstract] [Full Text] [Related]

  • 6. A Northern California Oncology Group randomized trial of leucovorin plus 5-fluorouracil versus sequential methotrexate, 5-fluorouracil, and leucovorin in patients with advanced colorectal cancer who failed treatment with 5-fluorouracil or 5-fluorodeoxyuridine alone.
    Valone FH, Kohler M, Fisher K, Hannigan J, Flam M, Gandara D, Hendrickson C, Richman E, Yu KP.
    NCI Monogr; 1987 Oct 01; (5):175-7. PubMed ID: 2963230
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Double modulation of 5-fluorouracil by leucovorin and low-dose methotrexate in advanced colorectal cancer.
    Stabuc B, Markovic A, Plesnicar A, Cizej TE.
    Neoplasma; 2000 Oct 01; 47(4):248-52. PubMed ID: 11043831
    [Abstract] [Full Text] [Related]

  • 10. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E, Beuzeboc P, Deffontaines D, Diéras V, Dorval T, Jouve M, Palangie T, Scholl S, Pouillart P.
    J Infus Chemother; 1996 Oct 01; 6(3):149-51. PubMed ID: 9229328
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Randomized trial comparing weekly bolus 5-fluorouracil plus leucovorin versus monthly 5-day 5-fluorouracil plus leucovorin in metastatic colorectal cancer.
    Wang WS, Lin JK, Chiou TJ, Liu JH, Fan FS, Yen CC, Lin TC, Jiang JK, Yang SH, Chen PM.
    Hepatogastroenterology; 2000 Oct 01; 47(36):1599-603. PubMed ID: 11149011
    [Abstract] [Full Text] [Related]

  • 15. [An institution-randomized trial of 5-fluorouracil and l-leucovorin therapy given monthly versus every two months to patients with advanced colorectal carcinoma].
    Hasegawa S, Akaike M, Yamamoto Y, Shiraishi R, Ozawa Y, Suzuki H, Miyazaki T, Kasahara A, Makino T, Tamura I, Tanabe H, Rino Y.
    Gan To Kagaku Ryoho; 2004 May 01; 31(5):729-33. PubMed ID: 15170981
    [Abstract] [Full Text] [Related]

  • 16. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
    Klaassen U, Wilke H, Seeber S.
    Semin Oncol; 1996 Oct 01; 23(5 Suppl 11):32-7. PubMed ID: 8893897
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R, López-Pousa A, Martínez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Martí JL, Lobo F, Pastor P, Valentí V, Belón J, Sánchez MA, Chaib C, Pallarés C, Antón A, Cervantes A, Paz-Ares L, Cortés-Funes H.
    J Clin Oncol; 2005 Dec 01; 23(34):8636-45. PubMed ID: 16275937
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.